Skip to content
Clinical Trials – home

Etoricoxib: A Comprehensive Guide for Patients

4 / 6
trials open to patients / all trials
4+
Countries

In short

Etoricoxib, also known by its brand name Arcoxia, is a medication that has been the subject of numerous clinical trials for its potential in treating various medical conditions. This article explores the use of etoricoxib in different clinical settings, from managing pain and inflammation to its effects on specific diseases. We'll delve into the findings of several studies to understand how this drug may benefit patients across different medical scenarios.

At a glance

Main Uses
Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute pain management
Dosage Range
30 mg to 120 mg daily, depending on the condition
Administration
Oral tablets, typically once daily
Unique Applications
Prevention of heterotopic ossification, Ramadan headache prevention, management of chemotherapy-induced pain
Potential Advantages
Fewer gastrointestinal side effects compared to traditional NSAIDs
Study Durations
Varied from a few days to several months
Outcome Measures
Pain reduction, improvement in disease activity scores, quality of life assessments

What is Etoricoxib?

Etoricoxib is a prescription medication that belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It is specifically known as a selective cyclooxygenase-2 (COX-2) inhibitor. Etoricoxib is marketed under various brand names, including Arcoxia, Tauxib, Algix, Exxiv, and Etozox.

How Does Etoricoxib Work?

Etoricoxib works by selectively blocking the COX-2 enzyme, which is responsible for producing substances in the body that cause pain and inflammation. By inhibiting this enzyme, etoricoxib helps reduce pain, swelling, and inflammation associated with various conditions. Unlike traditional NSAIDs, etoricoxib is designed to have fewer gastrointestinal side effects.

Conditions Treated with Etoricoxib

Etoricoxib is used to treat several conditions characterized by pain and inflammation, including:

  • Osteoarthritis: A common form of arthritis caused by wear and tear of joint cartilage
  • Rheumatoid Arthritis: An autoimmune disease that causes inflammation in the joints
  • Ankylosing Spondylitis: A type of arthritis that primarily affects the spine
  • Gout: A form of arthritis caused by the buildup of uric acid crystals in the joints
  • Acute Pain: Including postoperative pain and dental pain

Dosage and Administration

The dosage of etoricoxib varies depending on the condition being treated:

  • For ankylosing spondylitis, the recommended dose is typically 90 mg once daily
  • For osteoarthritis, rheumatoid arthritis, and chronic pain, doses may range from 30 mg to 90 mg once daily
  • For acute pain and gout, higher doses of up to 120 mg once daily may be prescribed for short periods

Etoricoxib is usually taken orally (by mouth) once a day, with or without food.

Effectiveness of Etoricoxib

Several clinical trials have demonstrated the effectiveness of etoricoxib in treating various conditions:

  • In patients with ankylosing spondylitis, etoricoxib has shown significant improvement in pain and function compared to placebo
  • For postoperative pain after total knee replacement surgery, etoricoxib has been found to reduce pain and the need for additional pain medication
  • In rheumatoid arthritis patients, etoricoxib has demonstrated effectiveness in reducing pain and improving joint function

Potential Side Effects

While etoricoxib is generally well-tolerated, it can cause side effects in some patients. Common side effects may include:

  • Gastrointestinal issues (such as stomach discomfort or nausea)
  • Headache
  • Dizziness
  • Elevated blood pressure

More serious side effects, although rare, can include cardiovascular events and gastrointestinal bleeding. It's important to discuss potential risks with your healthcare provider.

Special Considerations

There are some important considerations when using etoricoxib:

  • Cardiovascular Risk: Like other NSAIDs, etoricoxib may increase the risk of heart attack and stroke. This risk may be higher with longer use or in people with existing heart disease.
  • Gastrointestinal Protection: While etoricoxib is designed to have fewer gastrointestinal side effects than traditional NSAIDs, some patients may still require additional stomach protection.
  • Pregnancy and Breastfeeding: Etoricoxib should be avoided during pregnancy, especially in the third trimester, and while breastfeeding unless specifically recommended by a healthcare provider.
  • Interactions: Etoricoxib can interact with other medications, including blood thinners and certain blood pressure medications. Always inform your healthcare provider about all medications you are taking.

Questions people often ask

Conditions where Etoricoxib is being studied

Each condition opens its own overview and trial list

Trials with Etoricoxib

Recruiting trials first

See all 6 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.